Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI)

Pancreatic adenocarcinoma continues to be a leading cause of cancer death in the Western world and is amongst the leading gastrointestinal cancers. The incidence of pancreatic cancer has been stable or slowly rising in the past few decades. Overall the prognosis is poor with 5-year survival rates st...

Descripción completa

Detalles Bibliográficos
Autor principal: Francis, Isaac R.
Formato: Texto
Lenguaje:English
Publicado: e-Med 2007
Materias:
Focus on: Pancreatic Neoplasms
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727968/
https://www.ncbi.nlm.nih.gov/pubmed/17921087
http://dx.doi.org/10.1102/1470-7330.2007.9010
_version_ 1782170715896676352
author Francis, Isaac R.
author_facet Francis, Isaac R.
author_sort Francis, Isaac R.
collection PubMed
description Pancreatic adenocarcinoma continues to be a leading cause of cancer death in the Western world and is amongst the leading gastrointestinal cancers. The incidence of pancreatic cancer has been stable or slowly rising in the past few decades. Overall the prognosis is poor with 5-year survival rates still under 5%. Therefore early detection and accurate staging of these tumors is crucial for optimal treatment.
format Text
id pubmed-2727968
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher e-Med
record_format MEDLINE/PubMed
spelling pubmed-27279682009-10-01 Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI) Francis, Isaac R. Cancer Imaging Focus on: Pancreatic Neoplasms Pancreatic adenocarcinoma continues to be a leading cause of cancer death in the Western world and is amongst the leading gastrointestinal cancers. The incidence of pancreatic cancer has been stable or slowly rising in the past few decades. Overall the prognosis is poor with 5-year survival rates still under 5%. Therefore early detection and accurate staging of these tumors is crucial for optimal treatment. e-Med 2007-10-01 /pmc/articles/PMC2727968/ /pubmed/17921087 http://dx.doi.org/10.1102/1470-7330.2007.9010 Text en © 2007 International Cancer Imaging Society
spellingShingle Focus on: Pancreatic Neoplasms
Francis, Isaac R.
Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI)
title Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI)
title_full Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI)
title_fullStr Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI)
title_full_unstemmed Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI)
title_short Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI)
title_sort pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (mdct) and magnetic resonance imaging (mri)
topic Focus on: Pancreatic Neoplasms
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727968/
https://www.ncbi.nlm.nih.gov/pubmed/17921087
http://dx.doi.org/10.1102/1470-7330.2007.9010
work_keys_str_mv AT francisisaacr pancreaticadenocarcinomadiagnosisandstagingusingmultidetectorrowcomputedtomographymdctandmagneticresonanceimagingmri

Ejemplares similares